Literature DB >> 33687053

Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.

Yijin Chen1,2,3, Tong Xu1,2,3, Mengsha Li1,2,3, Chuling Li1,2,3, Yusheng Ma1,2,3, Guojun Chen1,2,3, Yili Sun1,2,3, Hao Zheng1,2,3, Guangkai Wu1,2,3, Wangjun Liao4, Yulin Liao1,2,3, Yanmei Chen1,2,3, Jianping Bin1,2,3.   

Abstract

Post-translational modification (PTM) by small ubiquitin-like modifier (SUMO) is a key regulator of cell proliferation and can be readily reversed by a family of SUMO-specific proteases (SENPs), making SUMOylation an ideal regulatory mechanism for developing novel therapeutic strategies for promoting a cardiac regenerative response. However, the role of SUMOylation in cardiac regeneration remains unknown. In the present study, we assessed whether targeting protein kinase B (Akt) SUMOylation can promote cardiac regeneration. Quantitative PCR and Western blotting results showed that small ubiquitin-like modifier-specific protease 2 (SENP2) is up-regulated during postnatal heart development. SENP2 deficiency promoted P7 and adult cardiomyocyte (CM) dedifferentiation and proliferation both in vitro and in vivo. Mice with SENP2 deficiency exhibited improved cardiac function after MI due to CM proliferation and angiogenesis. Mechanistically, the loss of SENP2 up-regulated Akt SUMOylation levels and increased Akt kinase activity, leading to a decrease in GSK3β levels and subsequently promoting CM proliferation and angiogenesis. In summary, inhibition of SENP2-mediated Akt deSUMOylation promotes CM differentiation and proliferation by activating the Akt pathway. Our results provide new insights into the role of SUMOylation in cardiac regeneration.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Akt pathway; Cardiac regeneration; SENP2; SUMOylation

Year:  2021        PMID: 33687053     DOI: 10.1042/CS20201408

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Role of Posttranslational Modifications of Proteins in Cardiovascular Disease.

Authors:  Yong-Ping Liu; Tie-Ning Zhang; Ri Wen; Chun-Feng Liu; Ni Yang
Journal:  Oxid Med Cell Longev       Date:  2022-07-09       Impact factor: 7.310

2.  Regulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis.

Authors:  Xinyi Wang; Ting Liu; Yifei Huang; Yifeng Dai; Hui Lin
Journal:  Open Biol       Date:  2021-11-10       Impact factor: 6.411

3.  Identification of Natural Products as SENP2 Inhibitors for Targeted Therapy in Heart Failure.

Authors:  Somayye Taghvaei; Farzaneh Sabouni; Zarrin Minuchehr
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

4.  Small ubiquitin-related modifier (SUMO)ylation of SIRT1 mediates (-)-epicatechin inhibited- differentiation of cardiac fibroblasts into myofibroblasts.

Authors:  Yingchun Luo; Jing Lu; Zeng Wang; Lu Wang; Guodong Wu; Yuanyuan Guo; Zengxiang Dong
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

5.  SENP2 Reduces Hepatocellular Carcinoma Stemness and Improves Sorafenib Sensitivity Through Inactivating the AKT/GSK3β/CTNNB1 Pathway.

Authors:  Xiaohui Tang; Bohao Liu; Chen Zhang; Wenbin Tang; Shitian Liang; Yadan Xiao; Ruoyu Deng; Zhuan Li
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.